Abeona Therapeutics Inc vs VanEck Video Gaming and eSports ETF — how do they compare? Abeona Therapeutics Inc trades at $7.4 (market cap $421.19M), while VanEck Video Gaming and eSports ETF trades at $97.96. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | ESPO | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.45 | $122.30 |
52-Week Low | $4.17 | $85.25 |
Enterprise Value | $276.10M | — |
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $7.46, up 0.13% with strong technical momentum as moving averages signal bullish sentiment. The company shows exceptional profitability with 454.86% net income margin and 70.99% ROE, though revenue remains modest at $5.82M. Recent positive developments include CMS granting NTAP status for ZEVASKYN and expanding treatment centers, while consistently beating earnings expectations.
Outlook remains positive with analyst consensus at 66.7% buy ratings, but risks include shareholder investigation and high RSI levels suggesting overbought conditions. The stock's valuation appears reasonable with P/E of 7.78, though negative operating cash flow requires monitoring as the company scales commercialization efforts.
ESPO trades at $97.98, down 1.63% today, with technical indicators showing a bullish bias as moving averages and oscillators signal buying opportunities. The stock shows strong momentum with ADX readings indicating a trending market. Support levels are established at $96, $97, and $98, while resistance sits at $100, $101, and $102.
The bullish technical setup suggests potential upside toward resistance levels, though fundamental analysis is limited due to unavailable financial ratios. Investors should monitor upcoming earnings reports for revenue growth and profitability metrics to validate the technical strength with fundamental support.
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →